Metacrine, Inc.
MTCR · NASDAQ
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $1 | $2 | $7 | $9 |
| G&A Expenses | $4 | $3 | $5 | $4 |
| SG&A Expenses | $4 | $3 | $5 | $4 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | -$0 | $0 | $0 |
| Operating Expenses | $5 | $6 | $12 | $13 |
| Operating Income | -$5 | -$6 | -$13 | -$13 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$6 | -$6 | -$13 | -$14 |
| Tax Expense | -$0 | $0 | $0 | $0 |
| Net Income | -$5 | -$7 | -$13 | -$14 |
| % Margin | – | – | – | – |
| EPS | -0.13 | -0.16 | -0.31 | -0.33 |
| % Growth | 18.8% | 48.4% | 6.1% | – |
| EPS Diluted | -0.13 | -0.16 | -0.31 | -0.33 |
| Weighted Avg Shares Out | 43 | 42 | 42 | 42 |
| Weighted Avg Shares Out Dil | 43 | 42 | 42 | 42 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $1 | -$0 |
| EBITDA | -$5 | -$6 | -$12 | -$14 |
| % Margin | – | – | – | – |